Listing 1 - 3 of 3 |
Sort by
|
Choose an application
When Ehrlich discovered the first evidence of the blood-brain barrier in 1885, he probably did not perceive the Great Wall that remained hidden from consciousness inside the central nervous system. Ehrlich had observed that acidic vital dyes did not stain the brain if they were injected into the blood stream. A century ago (1913), Goldman showed that the injection of trypan blue in the cerebrospinal fluid stained only the brain, but not the other organs. For almost a century it was thought that the blood-brain barrier (BBB) consisted in a physical barrier, resulting from the restricted permeability of the cerebral endothelial cell layer, as they are joined by tight junctions. However, as scientists are always looking for news in what is already discovered, in the end of the 20th century we had evidences that cerebral endothelial and glial cells express several drug metabolizing enzymes consisting in a second protection system: a metabolic barrier. Furthermore, the drugs and their metabolites must overcome the activity of several multidrug resistance proteins that function as ATP-dependent efflux pumps, consisting in the third line of defence: the active barrier. Therefore, the way the BBB actually works should be better explained. Several endogenous compounds, as well as xenobiotics, may be activated by enzymes of the metabolic barrier, generating reactive oxygen species that could damage neurons. Therefore, endothelial and glial cells possess endogenous protecting compounds and enzymes against oxidants, consisting in an antioxidant barrier. When all these systems fail, glial cells, mainly microglia, secrete cytokines in an attempt to crosstalk with defence cells asking for help, which consists in an immune barrier. In cerebral regions that are devoid of the physical barrier, such as circumventricular organs, the metabolic, active, antioxidant and immune barriers are reinforced. It is important to understand how cells involved in the BBB interact with one another and the dynamic mechanisms of their functions. This Research Topic published in this e-Book considers recent highlights in BBB structure, cell and molecular biology, biotransformation, physiology, pathology, pharmacology, immunology and how these basic knowledges can be applied in drug discovery and clinical researches, rewriting what is already written, and paving the way that goes to the Great Wall in the Frontiers of the Brain in this new century that is just beginning.
Neuroscience --- Human Anatomy & Physiology --- Health & Biological Sciences --- glial cells --- Stroke --- Cerebral endothelial cells --- BBB --- Oxidative Stress --- Glioma --- Blood Brain Barrier --- xenobiotic metabolizing enzymes --- Parkinsons disease --- Neuroinflammation
Choose an application
neurology --- movement disorder --- parkinsons --- neuroscience --- Movement disorders --- Movement Disorders. --- Movement disorders. --- Dyskinesia --- Dyskinesias --- Motor disorders --- Disabilities --- Nervous system --- Movement Disorder Syndromes --- Dyskinesia Syndromes --- Etat Marbre --- Status Marmoratus --- Dyskinesia Syndrome --- Movement Disorder --- Movement Disorder Syndrome --- Psychomotor Disorders --- Diseases --- Movement Disorders
Choose an application
Although the subthalamic nucleus (STN) is involved in regulating motor function, and inactivation of this structure relieves the motor symptoms in Parkinsonian patients, recent data indicate that corticosubthalamic connections are involved in both the regulation of attention and the ability to withhold from responding. Considerable evidence suggests that the neural circuitry underlying such behavioural disinhibition or impulsive action can be at least partially dissociated from that implicated in impulsive decision-making and it has been suggested that the tendency to choose impulsively is related to the ability to form and use Pavlovian associations. To explore these hypotheses further, STN-lesioned rats were tested on the delay-discounting model of impulsive choice, where impulsivity is defined as the selection of a small immediate over a larger delayed reward, as well as in a rodent autoshaping paradigm. In contrast to previous reports of increased impulsive action, STN lesions decreased impulsive choice but dramatically impaired the acquisition of the autoshaping response. When the STN was lesioned after the establishment of autoshaping behaviour, lesioned subjects were more sensitive to the omission of reward, indicative of a reduction in the use of Pavlovian associations to control autoshaping performance. These results emphasize the importance of the STN in permitting conditioned stimulus-unconditioned stimulus associations to regulate goal-seeking, a function which may relate to the alterations in impulsive choice observed in the delay-discounting task. These data bear a striking similarity to those observed after lesions of the orbitofrontal cortex and are suggestive of an important role for corticosubthalamic connections in complex cognitive behaviour
Ability. --- Accumbens core. --- Acquisition. --- Anterior cingulate. --- Association. --- Attention. --- Attentional performance. --- Basal ganglia. --- Bear. --- Behaviour. --- Choice. --- Conditioning. --- Control. --- Cortex. --- Deep brain-stimulation. --- Delay-discounting. --- Disinhibition. --- Excitotoxic lesions. --- Frontosubthalamic pathway. --- Function. --- Impulsivity. --- Lesion. --- Lesions. --- Model. --- Motivation. --- Nucleus. --- Obsessive-compulsive disorder. --- Orbitofrontal cortex. --- Parkinsons-disease. --- Performance. --- Perseveration. --- Rat. --- Rats. --- Reaction-time-task. --- Reduction. --- Regulation. --- Response. --- Reward. --- Rodent. --- Selection. --- Stimulus. --- Striatal dopamine depletion. --- Striking. --- Subthalamic nucleus. --- Task. --- Time.
Listing 1 - 3 of 3 |
Sort by
|